FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Sylvester

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Clinical Trials, Phase III as Topic

Co-author Network

Publications

TOP 3
Willem Oosterlinck; Richard Sylvester; Marco Babjuk; Eero Kaasinen; Andreas Böhle; Juan Palou Redorta; Morgan Rouprêt
Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?
Willem Oosterlinck; Ziya Kirkali; Richard Sylvester; Fernando Calais da Silva; Christer Busch; Ferran Algaba; Sandra Collette; Aldo Bono
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).
Adrian P M van der Meijden; Richard Sylvester; Willem Oosterlinck; Eduardo Solsona; Andreas Boehle; Bernard Lobel; Erkki Rintala
EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Sylvester (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Willem Oosterlinck; Richard Sylvester; Marco Babjuk; Eero Kaasinen; Andreas Böhle; Juan Palou Redorta; Morgan Rouprêt
Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?
European urology 2011;59(3):374-6.
2011: Willem Oosterlinck; Ziya Kirkali; Richard Sylvester; Fernando Calais da Silva; Christer Busch; Ferran Algaba; Sandra Collette; Aldo Bono
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).
European urology 2011;59(3):438-46.
2005: Adrian P M van der Meijden; Richard Sylvester; Willem Oosterlinck; Eduardo Solsona; Andreas Boehle; Bernard Lobel; Erkki Rintala
EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ.
European urology 2005;48(3):363-71.
2004: J R Oddens; Adrian P M van der Meijden; Richard Sylvester
One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?
European urology 2004;46(3):336-8.
2004: Willem Oosterlinck; Eduardo Solsona; Adrian P M van der Meijden; Richard Sylvester; A Böhle; E Rintala; Bernard Lobel
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma.
European urology 2004;46(2):147-54.
2001: Willem Oosterlinck; A V Bono; D Mack; R Hall; Richard Sylvester; C de Balincourt; Maurizio Brausi
Frequency of positive biopsies after visual disappearance of superficial bladder cancer marker lesions.
European urology 2001;40(5):515-7.
2001: Gerhard Jakse; R Hall; Aldo V Bono; W Höltl; P Carpentier; J P Spaander; Adrian P M van der Meijden; Richard Sylvester
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861.
European urology 2001;40(2):144-50.
2001: Adrian P M van der Meijden; Maurizio Brausi; V Zambon; W Kirkels; C de Balincourt; Richard Sylvester
Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial.
The Journal of urology 2001;166(2):476-81.
2001: D Mack; W Höltl; P Bassi; Maurizio Brausi; P Ferrari; C de Balincourt; Richard Sylvester
The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder.
The Journal of urology 2001;165(2):401-3.
2000: Adrian P M van der Meijden; Richard Sylvester; Laurence Collette; A Bono; F Ten Kate
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials.
The Journal of urology 2000;164(5):1533-7.
2000: Karl-Heinz Kurth; Christian Bouffioux; Richard Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; Maurizio Brausi
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
European urology 2000;37 Suppl 3():1-9.
1999: Adrian P M van der Meijden; Willem Oosterlinck; Maurizio Brausi; Karl-Heinz Kurth; Richard Sylvester; C de Balincourt
Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee.
European urology 1999;35(4):267-71.
1999: Geertjan van Tienhoven; Adri C Voogd; Johannes L Peterse; M Nielsen; K W Andersen; F Mignolet; Richard Sylvester; Ian S Fentiman; E van der Schueren; K van Zijl; Mogens Blichert-Toft; Harry Bartelink; JA van Dongen
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1999;35(1):32-8.
1997: Karl-Heinz Kurth; U Tunn; R Ay; F H Schröder; M Pavone-Macaluso; F Debruyne; F ten Kate; M de Pauw; Richard Sylvester
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
The Journal of urology 1997;158(2):378-84.
1997: P D Vegt; Adrian P M van der Meijden; Richard Sylvester; Maurizio Brausi; W Höltl; C de Balincourt
Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911.
The Journal of urology 1997;157(4):1246-9.
1997: Harry Bartelink; R D Rubens; E van der Schueren; Richard Sylvester
Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):207-15.